Brigit Biofarmaka Teknologi Tbk. vs Yanaprima Hastapersada Tbk — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Yanaprima Hastapersada Tbk trades at Rp605 (market cap 404.14B, 34.6K 24h volume). The key difference: Yanaprima Hastapersada Tbk is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 34.6K). Which is the better fit depends on your goals.
| OBAT | YPAS | |
|---|---|---|
Market Cap | 172.82B | 404.14B |
Volume | 592.2K | 34.6K |
Lot | 5.92K | 346 |
Turnover | 147.05M | 20.55M |
Average Price | 248.31 | 593.83 |
Value | 147.05M | 20.55M |
Indicative Equilibrium Price | 254 | 605 |
Indicative Equilibrium Volume | 10 | 70 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Yanaprima Hastapersada Tbk (the Company) was established in Indonesia based on Notarial Deed No. 38 of Emmy Hartati Yunizar, S.H., dated December 14, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 5 of Marina Soewana, S.H., dated Nov 1, 2007, concerning among others, the change of capital stucture, Company name and public offering.
Read more on YPAS →